Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7411220> ?p ?o }
Showing triples 1 to 95 of
95
with 100 triples per page.
- Q7411220 subject Q16816237.
- Q7411220 subject Q5312304.
- Q7411220 subject Q6647427.
- Q7411220 subject Q6941298.
- Q7411220 subject Q7024930.
- Q7411220 subject Q7040303.
- Q7411220 subject Q7216950.
- Q7411220 subject Q7773699.
- Q7411220 subject Q8246150.
- Q7411220 subject Q8247044.
- Q7411220 subject Q8247476.
- Q7411220 subject Q8247687.
- Q7411220 subject Q8248427.
- Q7411220 subject Q8419300.
- Q7411220 subject Q8723280.
- Q7411220 subject Q8723305.
- Q7411220 subject Q8964470.
- Q7411220 subject Q9948307.
- Q7411220 abstract "Samuel D. "Sam" Waksal, Ph.D., (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the landmark cancer drug Erbitux (cetuximab). During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members. He was convicted of several securities violations, served time in federal prison, and was released.".
- Q7411220 wikiPageExternalLink bd062502.shtml.
- Q7411220 wikiPageExternalLink national1256EDT0601.DTL.
- Q7411220 wikiPageExternalLink sam_waksal.asp.
- Q7411220 wikiPageExternalLink main576328.shtml.
- Q7411220 wikiPageExternalLink big_break_for_imclone_sam_146355.htm.
- Q7411220 wikiPageExternalLink 03CND-MARTHA.html.
- Q7411220 wikiPageWikiLink Q101929.
- Q7411220 wikiPageWikiLink Q132305.
- Q7411220 wikiPageWikiLink Q1400015.
- Q7411220 wikiPageWikiLink Q1476505.
- Q7411220 wikiPageWikiLink Q151679.
- Q7411220 wikiPageWikiLink Q160149.
- Q7411220 wikiPageWikiLink Q163727.
- Q7411220 wikiPageWikiLink Q16816237.
- Q7411220 wikiPageWikiLink Q204711.
- Q7411220 wikiPageWikiLink Q234606.
- Q7411220 wikiPageWikiLink Q266423.
- Q7411220 wikiPageWikiLink Q28813.
- Q7411220 wikiPageWikiLink Q309331.
- Q7411220 wikiPageWikiLink Q310229.
- Q7411220 wikiPageWikiLink Q321245.
- Q7411220 wikiPageWikiLink Q334122.
- Q7411220 wikiPageWikiLink Q3627314.
- Q7411220 wikiPageWikiLink Q41506.
- Q7411220 wikiPageWikiLink Q420296.
- Q7411220 wikiPageWikiLink Q4444818.
- Q7411220 wikiPageWikiLink Q4570975.
- Q7411220 wikiPageWikiLink Q4856011.
- Q7411220 wikiPageWikiLink Q487907.
- Q7411220 wikiPageWikiLink Q49120.
- Q7411220 wikiPageWikiLink Q4914946.
- Q7411220 wikiPageWikiLink Q525302.
- Q7411220 wikiPageWikiLink Q5312304.
- Q7411220 wikiPageWikiLink Q5440137.
- Q7411220 wikiPageWikiLink Q5440147.
- Q7411220 wikiPageWikiLink Q5440344.
- Q7411220 wikiPageWikiLink Q6001772.
- Q7411220 wikiPageWikiLink Q6345613.
- Q7411220 wikiPageWikiLink Q637156.
- Q7411220 wikiPageWikiLink Q6647427.
- Q7411220 wikiPageWikiLink Q664846.
- Q7411220 wikiPageWikiLink Q6735709.
- Q7411220 wikiPageWikiLink Q679692.
- Q7411220 wikiPageWikiLink Q6941298.
- Q7411220 wikiPageWikiLink Q7024930.
- Q7411220 wikiPageWikiLink Q7040303.
- Q7411220 wikiPageWikiLink Q7216950.
- Q7411220 wikiPageWikiLink Q7325.
- Q7411220 wikiPageWikiLink Q7773699.
- Q7411220 wikiPageWikiLink Q7962625.
- Q7411220 wikiPageWikiLink Q8246150.
- Q7411220 wikiPageWikiLink Q8247044.
- Q7411220 wikiPageWikiLink Q8247476.
- Q7411220 wikiPageWikiLink Q8247687.
- Q7411220 wikiPageWikiLink Q8248427.
- Q7411220 wikiPageWikiLink Q8419300.
- Q7411220 wikiPageWikiLink Q849697.
- Q7411220 wikiPageWikiLink Q854623.
- Q7411220 wikiPageWikiLink Q8723280.
- Q7411220 wikiPageWikiLink Q8723305.
- Q7411220 wikiPageWikiLink Q8964470.
- Q7411220 wikiPageWikiLink Q90.
- Q7411220 wikiPageWikiLink Q9948307.
- Q7411220 type Person.
- Q7411220 type Agent.
- Q7411220 type Criminal.
- Q7411220 type Person.
- Q7411220 type Agent.
- Q7411220 type NaturalPerson.
- Q7411220 type Thing.
- Q7411220 type Q215627.
- Q7411220 type Q2159907.
- Q7411220 type Q5.
- Q7411220 type Person.
- Q7411220 comment "Samuel D. "Sam" Waksal, Ph.D., (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the landmark cancer drug Erbitux (cetuximab).".
- Q7411220 label "Samuel D. Waksal".